All treatments
Treatment
Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic use (Phase IV)
Herpes zoster after recombinant herpes zoster vaccination - Immediate post-RHZ-vaccination evolution of CMI, HMI and lymphocyte count and typing.
This study looks at how Shingrix, a vaccine for shingles, changes your immune system right after you get the shot. Researchers want to see how your body's defence against the chickenpox virus reacts in the first three weeks after vaccination.
For: Herpes Zoster virus preventionBelgium - Ongoing, recruitingPhase III and phase IV (Integrated)
Prospective Randomized trial of Everolimus replacing MMF/MP Acid by the RECOVAC consortium to increase VACcine response in kidney transplant patients
This study looks at how well kidney transplant patients respond to COVID-19 and shingles vaccines when their anti-rejection medication is changed. It compares two different drug treatment plans to see which one helps the body make more protective antibodies.
For: kidney transplantation · COVID-19 · Herpes ZosterNetherlands